Constipation in Parkinson’s Disease: A Systematic Review and Meta-Analysis
European Neurology · 2023 · 86 (1) · 34-44
DOI: 10.1159/000527513 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Neurology, online erschienen am 05.12.2022. Verfasst von Lulu Yao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China, redlu1989@163.com. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Constipation is a common nonmotor symptom of Parkinson’s disease (PD) and has been reported to increase the risk of developing PD. However, previous studies have yielded conflicting results. Understanding this correlation may promote early diagnosis and treatment of PD, which could help patients improve their quality of life. This study aimed to investigate the association between constipation and PD onset.
Methods
The study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-analyses of Observational Studies in Epidemiology (MOOSE) guidelines. We searched the Medline, Embase, Scopus, SINOMED, and Cochrane databases as well as specific journals from inception to September 2021 for observational studies that evaluated the association between constipation and the risk of PD. The Newcastle-Ottawa Scale was used to evaluate the methodological quality of the included studies. Associations were summarized as odds ratios (ORs) using a random-effects model. Subgroup, meta-regression, and sensitivity analyses were performed.
Results
Seventeen studies comprising 3,024,193 participants (case-control = 1,636,831; cohort = 1,387,362) were eligible for inclusion. The pooled OR for the association between constipation and PD was 2.36 (95% confidence interval: 1.93–2.88), although strong heterogeneity was observed (I2 = 90%, p < 0.01). Subgroup and meta-regression analyses indicated that study design and disease duration were the major sources of heterogeneity. A sensitivity analysis confirmed the stability of the outcomes. In addition, the prevalence of among those with prodromal PD was 20%, whereas it was only 11% in the control group (p < 0.01). Moreover, there were no significant age-based differences in constipation between the prodromal stage of PD patients and the controls (p > 0.05).
Conclusion
Constipation has a relatively high incidence in the prodromal phase of PD and is associated with an increased risk of developing PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China, redlu1989@163.com.
- Department of Traditional Chinese Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Department of Neurobiology, Capital Medical University, Beijing, China.
Zitieren
APA
Yao, L., Liang, W., Chen, J., Wang, Q., & Huang, X. (2023). Constipation in Parkinson’s Disease: A Systematic Review and Meta-Analysis. European Neurology, 86(1), 34-44. https://doi.org/10.1159/000527513
Vancouver
Yao L, Liang W, Chen J, Wang Q, Huang X. Constipation in Parkinson’s Disease: A Systematic Review and Meta-Analysis. European Neurology. 2023;86(1):34-44. doi:10.1159/000527513
BibTeX
@article{Yao2023,
author = {Yao, Lulu and Liang, Wei and Chen, Jiahao and Wang, Qian and Huang, Xiaobo},
title = {Constipation in Parkinson’s Disease: A Systematic Review and Meta-Analysis},
journal = {European Neurology},
year = {2023},
volume = {86},
number = {1},
pages = {34--44},
doi = {10.1159/000527513}
}
EUVIMED